AIDS-Related Complex: Clinical Trials

283 trials for AIDS-Related Complex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

270 completed, 5 terminated, 4 withdrawn, 2 recruiting. 102 Phase 1, 82 Not applicable, 56 Phase 2, 31 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 1102Completed 98, Withdrawn 3, Terminated 1
Not applicable82Completed 81, Terminated 1
Phase 256Completed 53, Terminated 1, Unknown 1, Withdrawn 1
Phase 331Completed 30, Terminated 1
Phase 41Completed 1

Follow AIDS-Related Complex: new trials by email Literature Review of AIDS-Related Complex trials Research Report on AIDS-Related Complex

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Augmented Renal Clearance in Neurocritical Care
TBI (Traumatic Brain Injury), Status Epilepticus
RecruitingUniversity of Alberta5122021-10-012026-02-18
Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
Betalutin with lilotomab dose 1, Betalutin with lilotomab dose 2 - Non-Hodgkin Lymphoma
Phase 1WithdrawnNordic Nanovector2017-12-192019-01-10
Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)
Betalutin - Relapsed, Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma
Phase 1CompletedNordic Nanovector182017-03-022024-01-16
ALS Research Collaborative
Amyotrophic Lateral Sclerosis, ALS (Amyotrophic Lateral Sclerosis)
RecruitingALS Therapy Development Institute20002014-09-122025-03-20
Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment
Cyclosporine combine with mycophenolate mofetil, Cyclophosphamide + pred - Anti-r-HuEpo Associated PRCA Subjects
Phase 3TerminatedChulalongkorn University82009-01-012014-01-29
Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity
captopril test - Primary Aldosteronism
UnknownNational Taiwan University Hospital1502008-01-012009-06-10
Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs
Aerosol Interferon-Gamma, Subcutaneous interferon-gamma, Placebo - Tuberculosis, AIDS-related Complex
Phase 2CompletedNYU Langone Health892005-04-012016-12-16
A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.
Stavudine - HIV Infections
Not applicableCompletedBristol-Myers Squibb401995-01-012011-04-14
The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients
Amitriptyline hydrochloride, Amitriptyline hydrochloride placebo, Point acupuncture - HIV Infections, Peripheral Nervous System Disease
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)2601994-11-012021-11-03
A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols
Pneumonia, Pneumocystis Carinii, HIV Infections
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)5571994-10-012013-10-01
A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine
zidovudine, 2',3'-dideoxyinosine - AIDS-Related Complex, Acquired Immunodeficiency Syndrome
Phase 3CompletedNational Cancer Institute (NCI)421990-10-012008-03-04
Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment.
Peptide T, Placebo - HIV Infections, Cognition Disorders
Phase 2CompletedNational Institute of Mental Health (NIMH)2151990-01-012017-02-28
A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.
Peptide T - HIV Infections
Phase 1CompletedNational Institute of Mental Health (NIMH)301988-01-012015-03-03
Pulmonary Complications of HIV Infection Study (PACS)
Acquired Immunodeficiency Syndrome, HIV Infections
CompletedNational Heart, Lung, and Blood Institute (NHLBI)1987-09-012016-03-16
An Open-Label Safety Program for the Use of Zalcitabine (Dideoxycytidine; ddC) in Pediatric Patients With Symptomatic HIV Infection Who Have Failed or Are Intolerant to AZT Monotherapy, or Who Have Completed Other ddC Protocols, or Are Ineligible for Other Ongoing Clinical Studies
Zalcitabine - HIV Infections
Not applicableCompletedHoffmann-La Roche6002005-06-24
A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
Ampligen - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)402021-11-03
A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3
Delavirdine mesylate, Lamivudine, Zidovudine - HIV Infections
Phase 3CompletedPharmacia and Upjohn12502005-06-24
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
CD4-IgG - HIV Infections, Pregnancy
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302005-06-24
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss
Nandrolone decanoate - HIV Infections, HIV Wasting Syndrome
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)382021-10-29
A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies
Trimetrexate glucuronate, Leucovorin calcium - Pneumonia, Pneumocystis Carinii, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2008-09-30

Showing 20 of 283. Sign in to see all of them.

Narrower conditions

HIV Infections (275)  ·  Acquired Immunodeficiency Syndrome (235)  ·  AIDS-Related Opportunistic Infections (18)  ·  Pneumonia, Pneumocystis (16)  ·  Candidiasis, Oral (8)  ·  Pregnancy Complications, Infectious (7)  ·  Chickenpox (5)  ·  Cytopenia (5)  ·  Lymphatic Diseases (5)  ·  Tuberculosis (5)  ·  Diarrhea (4)  ·  HIV Seropositivity (4)  ·  Herpes Zoster (4)  ·  Neoplasms (4)

Broader conditions

Blood-Borne Infections (283)  ·  Communicable Diseases (283)  ·  Genital Diseases (283)  ·  Immunologic Deficiency Syndromes (283)  ·  Infections (283)  ·  Lentivirus Infections (283)  ·  RNA Virus Infections (283)  ·  Retroviridae Infections (283)  ·  Sexually Transmitted Diseases (283)  ·  Sexually Transmitted Diseases, Viral (283)  ·  Slow Virus Diseases (283)  ·  Urogenital Diseases (283)  ·  Virus Diseases (283)  ·  Immune System Diseases (281)  ·  Bacterial Infections and Mycoses (40)

Interventions

Zidovudine (95)  ·  Didanosine (32)  ·  Zalcitabine (25)  ·  Lamivudine (12)  ·  Stavudine (12)  ·  Nevirapine (9)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (8)  ·  aldesleukin (8)  ·  Acyclovir (7)  ·  Inosine Pranobex (7)  ·  Saquinavir (7)  ·  Fluconazole (6)  ·  Nystatin (6)  ·  Ribavirin (5)  ·  CD4 Antigens (4)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (150)  ·  Glaxo Wellcome (21)  ·  Hoffmann-La Roche (11)  ·  Bristol-Myers Squibb (7)  ·  Newport Pharmaceuticals International (6)  ·  Gilead Sciences (5)  ·  Immunobiology Research Institute (4)  ·  Pharmacia and Upjohn (4)  ·  AJI Pharma USA (3)  ·  Argus Pharmaceuticals (3)  ·  Hoechst Marion Roussel (3)  ·  Janssen, LP (3)  ·  Merck Sharp & Dohme LLC (3)  ·  Pfizer (3)  ·  Sandoz (3)

Countries

United States (275)  ·  Puerto Rico (47)  ·  Tanzania (8)  ·  Canada (5)  ·  Germany (2)  ·  Brazil (1)  ·  Italy (1)  ·  South Africa (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Thailand (1)  ·  United Kingdom (1)

Top investigators

Corey L (4)  ·  Crumpacker C (4)  ·  Fischl MA (4)  ·  Para MF (4)  ·  Friedland G (3)  ·  Katzenstein D (3)  ·  M Ho (3)  ·  Merigan TC (3)  ·  Pollard R (3)  ·  Pomerantz R (3)  ·  Ptachcinski R (3)  ·  Richman D (3)  ·  Richman DD (3)  ·  Schooley RT (3)  ·  Van Dyke R (3)

Results publications

PMID 20103953, PMID 10225228, PMID 10634196, PMID 10969100, PMID 11115957, PMID 11794218, PMID 11986480, PMID 12042556, PMID 15173535, PMID 15470330, PMID 15750460, PMID 15764965, PMID 15886376, PMID 16220994, PMID 16849662, PMID 17003692, PMID 17101712, PMID 17296781, PMID 17392561, PMID 18363489, PMID 18413359, PMID 18647794, PMID 19131890, PMID 19188649, PMID 19753300, PMID 19827220, PMID 19827949, PMID 20083530, PMID 20117105, PMID 20865061, PMID 21190965, PMID 21323533, PMID 21666159, PMID 23753021, PMID 28154006, PMID 29535451, PMID 35396385, PMID 37334546, PMID 37461207, PMID 37604821, PMID 39707523, PMID 9708408, PMID 9917118

NIH funding

R01HL059832 (1), U01HL048534 (1)